CPH Chemie und Papier Holding (CPHN.SW) stock: key figures, P/E, revenue and dividend
Materials · Paper Products · Switzerland · ISIN CH0001624714
CPH Chemie und Papier Holding financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 447.86 m CHF | 334.06 m CHF |
| Gross profit | 162.31 m CHF | 159.51 m CHF |
| Operating income | 7.68 m CHF | 32.77 m CHF |
| EBIT | 12.67 m CHF | 31.56 m CHF |
| Net income | 4.65 m CHF | 23.36 m CHF |
| Diluted EPS – continuing operations | 0.78 CHF | 3.90 CHF |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CPH Chemie und Papier Holding
CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED displays. This segment also operates production facilities in Switzerland, Bosnia and Herzegovina, the USA, Canada, China, and India. The Perlen Packaging segment focuses on the pharmaceutical industry, supplying coated plastic films used primarily in blister packaging to protect medications, as well as vials and containers for medical use; and PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry. CPH Group AG was founded in 1818 and is based in Perlen, Switzerland.
More stocks
- Chengdu Qushui Science & Technology Co. Ltd. A (301336.SZ)
- Synmosa Biopharma (4114.TWO)
- Chongqing YuXin Pingrui Electronic Co. Ltd. (301107.SZ)
- RBB Bancorp (RBB)
- INTEKPLUS Co. Ltd (064290.KQ)
- Shenzhen Jiang and Associates Creative Design Co Ltd (300668.SZ)
- Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367.SZ)
- NeuroPace Inc (NPCE)
- Beijing Haohan Data Technology Co. Ltd. A (688292.SS)
- Beijing Hanyi Innovation Technology Co. Ltd. A (301270.SZ)
- Zhong Fu Tong Co Ltd (300560.SZ)
- Beijing Jingxi Culture&Tourism Co Ltd (000802.SZ)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.